Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 pa- tients of the 2011 2012 Pilot European Sentinel Registry. J Am Coll Car- diol. 2014;64:875 84. 13. Sorajja P, Vemulapalli S, Feldman T, et al. Outcomes with transcatheter mitral valve repair in the United States: an STS/ACC TVT registry report. J Am Coll Cardiol. 2017;70:2315 27. 14. Velazquez EJ, Lee KL, Jones RH, et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374: 1511 20. 15. Panza JA, Ellis AM, Al-Khalidi HR, et al. Myocardial viability and long-term outcomes in ischemic cardiomyopathy. N Engl J Med. 2019;381:739 48. 16. Ji Q, Zhao Y, Shen J, et al. Predictors of ischemic mitral regurgitation im- provement after surgical revascularization plus mitral valve repair for mod- erate ischemic mitral regurgitation. J Card Surg. 2020;35:528 35. 17. Kopjar T, Gasparovic H, Mestres CA, et al. Meta-analysis of concomitant mitral valve repair and coronary artery bypass surgery versus isolated coro- nary artery bypass surgery in patients with moderate ischaemic mitral re- gurgitation. Eur J Cardiothorac Surg. 2016;50:212 22. 18. Virk SA, Tian DH, Sriravindrarajah A, et al. Mitral valve surgery and cor- onary artery bypass grafting for moderate-to-severe ischemic mitral re- gurgitation: meta-analysis of clinical and echocardiographic outcomes. J Thorac Cardiovasc Surg. 2017;154:127 36. 7.3.3. Medical Therapy 1. SOLVD Investigators, Yusuf S, Pitt B, et al. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with re- duced left ventricular ejection fractions. N Engl J Med. 1992;327:685 91. 2. Eriksson SV, Eneroth P, Kjekshus J, et al. Neuroendocrine activation in rela- tion to left ventricular function in chronic severe congestive heart failure: a subgroup analysis from the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). Clin Cardiol. 1994;17:603 6. 3. 